Zenodo (CERN European Organization for Nuclear Research) · 2011 · 25 citations · 10 references
MedicinePharmacologyPlant SciencesProstate DiseaseReproductive MedicineSeed ScienceBenign Prostatic HyperplasiaProstate DisordersProstate PhysiologyProstatic PathologySeed ExtractionSeed TreatmentHistopathology Of Prostatic HyperplasiaProstatic AtrophySeed Phytochemical Content
Aims: To investigate the effects of methanolic extract of Citrullus lanatus seed<br> (MECLS) on experimentally induced benign prostate hyperplasia.<br> Study design: Animal model of experimentally induced prostatic hyperplasia.<br> Place and Duration of Study: Department of Anatomy, Faculty of Basic Medical<br> Sciences, Ikenne Campus, Ikenne, Ogun State, Nigeria, between May 2010 and August<br> 2010.<br> Methodology: Twenty adult male Wistar rats weighing about 135-180g were randomly<br> divided into four groups of five animals each. Group I, Normal control (NC) was given<br> corn oil as placebo 1g/Kg BW; Group II, Hormone treated control (HTC), Groups III, and<br> IV hormone and extract treated (HTEC), received continuous dosage of 300μg and<br> 80μg of testosterone (T) and estradiol (E2) respectively on alternate days for three<br> weeks subcutaneously in the inguinal region while the extract treated received an<br> additional 2g/Kg BW (low dose) and 4g/Kg BW (high dose) of extract orally for 4 weeks<br> after the successful induction of prostate enlargement. Immediately after induction some<br> animals were randomly selected and sacrificed for gross inspection of prostate<br> enlargement and sperm count evaluation, these procedures were repeated again after<br> four weeks of extract treatment. Portion of the prostate were taken and processed<br> routinely for paraffin embedding and stained with H&E.<br> Results: Hormone treatment did not affect the body weight of the animals; however it<br> caused a significant decrease in the weight of the testes and rendered all the rats<br> azoospermia. In addition, treatment with extracts caused a significant decrease in the<br> enlarged prostate, seminal vesicle and testes sizes in a dose related manner (P<0.05) compared to the hormone treated control. Histological examination of prostate revealed<br> that the methanolic extract caused significant changes in its histo-architecture. There<br> was an increase in the fibromuscular layer, decrease in prostatic acini size, shrinkage of<br> epithelium, and no infolding of the epithelium into the lumen, rather, it appeared flat<br> compared to the very distinct columnar epithelium of the hormone treated control and<br> conspicuousness of the acini. The extracts further caused a dose dependent reduction<br> in the prostates weight. PSA level was significantly lowered in both HTEC at low and<br> high doses (P<0.05) in dose dependent manner.<br> Conclusion: Administration of MECLS for one month reduced the prostate size<br> significantly (P< 0.05), both at high and low dose, but could not restore the initial size of<br> shrunken testes and severe oligospermia caused by the hormones. The histological<br> studies clearly establish MECLS as a potential candidate in management of androgen<br> dependent conditions like benign prostate hyperplasia.
10
Richard A. Bebb, Bradley D. Anawalt, R B Christensen et al. · The Journal of Clinical Endocrinology & Metabolism · 1996 · 199 citations